Tevogen Bio (TVGNW) Stock Analysis

What Tevogen Bio does

Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions. The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID. Tevogen Bio Holdings Inc. is headquartered in Warren, New Jersey.

Key metrics

ETFs linked to TVGNW

Broad-market and Healthcare sector ETFs an investor holding Tevogen Bio is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TVGNW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Tevogen Bio?

Tevogen Bio trades under the ticker TVGNW on NASDAQ.

Which exchange is TVGNW listed on?

TVGNW is listed on NASDAQ.

What sector does Tevogen Bio operate in?

Tevogen Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TVGNW in a portfolio?

PortView shows TVGNW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.